Symbols

ANRO

Alto Neuroscience·NYSE

--(--)

ANRO Profile

Alto Neuroscience, Inc.

A clinical-stage biopharmaceutical company in California

Industry

Pharmaceutical

Established Date

03/25/2019

Listing Date

02/02/2024

Exchange

New York Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.altoneuroscience.com

Security Type

Common stock

Office address

650 Castro Street, Suite 450 Mountain View, CA 94041

Business

Introduction

Alto Neuroscience, Inc., was incorporated in Delaware on March 25, 2019. The company is a clinical-stage biopharmaceutical company focused on developing personalized treatment options for mental illness by leveraging its precision psychiatry platform to identify brain biomarkers. Its R&D pipeline includes clinical-stage assets for major depression, bipolar depression, schizophrenia and Parkinson's disease.